Related Experiment Video
Updated: Jul 7, 2026

Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus
Published on: June 6, 2025
Mucormycosis: a rare but serious infection
Donna M Eichna1, Kim S Brown, Andrea Breen
1Inova Fairfax Hospital, Virginia, USA. donna.eichna@inova.com
Abstract:
Infection is among the leading causes of morbidity and mortality in patients undergoing bone marrow transplantation. Although all infections create difficulties, the most troublesome to those patients are fungal infections. Therapies used to prevent rejection and graft-versus-host disease, as well as an increase in poorly matched or unrelated donors, are believed to contribute to the increase of fungal infections. Mucormycosis, also known as zygomycosis, is an opportunistic fungal infection that is seen rarely in the clinical setting but can be found in patients who are severely neutropenic or immunosuppressed. Oncology nurses caring for bone marrow and peripheral blood stem cell transplantation recipients must know the warning signs of this deadly infection. Early detection and aggressive treatment are patients' best chances of survival.
Insights
Fungal infections, particularly mucormycosis, pose a severe risk to bone marrow transplant patients. Early detection and prompt treatment are crucial for survival in these immunocompromised individuals.
Area of Science:
- Mycology
- Transplantation Medicine
- Infectious Diseases
Background:
- Bone marrow transplantation (BMT) patients face significant risks of infection, a leading cause of morbidity and mortality.
- Fungal infections are particularly challenging in BMT recipients due to immunosuppressive therapies and increased use of unrelated donors.
- Mucormycosis (zygomycosis) is a rare but life-threatening opportunistic fungal infection affecting severely neutropenic and immunosuppressed patients.
Observation:
- Oncology nurses play a critical role in identifying early warning signs of mucormycosis in BMT patients.
- The incidence of fungal infections, including mucormycosis, is increasing in the context of BMT.
- Risk factors include immunosuppressive treatments for graft rejection and graft-versus-host disease.
Findings:
- Mucormycosis presents a rare but severe threat to immunocompromised BMT recipients.
- Identifying warning signs of this fungal infection is essential for patient care.
- Aggressive and timely treatment significantly improves survival rates.
Implications:
- Enhanced vigilance and education for oncology nurses are vital for early mucormycosis detection.
- Further research into preventative strategies and targeted therapies for fungal infections in BMT is warranted.
- Improved patient outcomes depend on prompt diagnosis and multidisciplinary management of opportunistic infections post-transplant.
Related Concept Videos
Fungal Group Zygomycota
Cryptococcal Meningitis
Candidiasis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia